Latest Zinc finger nuclease Stories
Novel ZFN Genome Editing Approach Results in Sustained Levels of Enzymes Associated with Hunter, Hurler and Gaucher Syndromes RICHMOND, Calif., Feb.
Hunter's Disease and Hurler's Disease Named as Sangamo's First Proprietary Programs in Lysosomal Storage Disorders RICHMOND, Calif., Jan. 12, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
mRNA Delivery a Natural Fit for ZFN-mediated Genome Editing Which Requires Only Transient Expression to Achieve a Permanent Therapeutic Effect RICHMOND, Calif., Jan.
In a new “proof of concept” experiment, scientists have managed to edit the genome of sperm-producing adult stem cells, creating a break in the DNA strands of a mutant gene in mouse cells then repairing it by replacing flawed segments with corrected ones.
RICHMOND, Calif., Oct. 16, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
Timeline for Hemophilia B IND Application Filing Targeting Second Quarter 2015 RICHMOND, Calif., Sept. 10, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
The CRISPR/Cas9 system enables accurate and efficient genetic engineering. ST.
CRISPR/Cas9 system allows researchers to quickly and precisely edit DNA ST.
First Clinical Application of Genome Editing Technology in Hematopoietic Stem/Progenitor Cells RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
Groundbreaking Nature Publication Describes Successful ZFN Driven Genome Editing in Long-Term Repopulating Stem Cells Necessary for Clinical Translation RICHMOND, Calif., May 28, 2014
- The governor of a province or people.